The Freesolve BTK RMS is designed for patients suffering from chronic limb-threatening ischemia (CLTI) BUELACH, Switzerland, March 21, 2024 /PRNewswire/ — BIOTRONIK has been granted Breakthrough Device Designation (BDD) from the US Food and Drug Administration (FDA) for the Freesolve™…
FDA Breakthrough Device Designation for BIOTRONIK Freesolve™ Below-the-Knee Resorbable Magnesium Scaffold (RMS)
This post was originally published on this site